Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Batal

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2024
C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after TransplantationBlanca Tarragón, Yonatan Peleg, Geetha Jagannathan, et al.
Kidney International|August 10, 2024
Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograftIbrahim Batal, Andrew J B Watts, Jean-Baptiste Gibier, et al.
Kidney International Reports|November 9, 2020
Impact of Deceased Donor Kidney Procurement Biopsy Technique on Histologic AccuracyS Ali Husain, Vaqar Shah, Hector Alvarado Verduzco, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 25, 2020
Reproducibility of Deceased Donor Kidney Procurement BiopsiesS Ali Husain, Kristen L King, Ibrahim Batal, et al.
Kidney International|October 6, 2018
Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allograftsDominick Santoriello, Syed A Husain, Sacha A De Serres, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 10, 2021
A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort studyCarrie A Schinstock, Medhat Askar, Serena M Bagnasco, et al.
Glomerular Diseases|April 22, 2022
Clinical Predictors and Prognosis of Recurrent IgA Nephropathy in the Kidney AllograftCatherine R Kavanagh, Francesca Zanoni, Rita Leal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 7, 2025
Association of Collapsing Glomerulopathy with Donor Apolipoprotein L1 Risk Variants in Kidney Allografts from Black DonorsIbrahim Batal, Alexei V Mikhailov, Syed A Husain, et al.
Clinical Transplantation|April 28, 2025
Rethinking the Diagnosis and Management of Antibody-Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group RecommendationsRuth Sapir-Pichhadze, Medhat Askar, Matthew Cooper, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to TreatmentCarmen Lefaucheur, Denis Viglietti, Luis G Hidalgo, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2024
C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after TransplantationBlanca Tarragón, Yonatan Peleg, Geetha Jagannathan, et al.
Kidney International|August 10, 2024
Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograftIbrahim Batal, Andrew J B Watts, Jean-Baptiste Gibier, et al.
Kidney International Reports|November 9, 2020
Impact of Deceased Donor Kidney Procurement Biopsy Technique on Histologic AccuracyS Ali Husain, Vaqar Shah, Hector Alvarado Verduzco, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 25, 2020
Reproducibility of Deceased Donor Kidney Procurement BiopsiesS Ali Husain, Kristen L King, Ibrahim Batal, et al.
Kidney International|October 6, 2018
Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allograftsDominick Santoriello, Syed A Husain, Sacha A De Serres, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 10, 2021
A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort studyCarrie A Schinstock, Medhat Askar, Serena M Bagnasco, et al.
Glomerular Diseases|April 22, 2022
Clinical Predictors and Prognosis of Recurrent IgA Nephropathy in the Kidney AllograftCatherine R Kavanagh, Francesca Zanoni, Rita Leal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 7, 2025
Association of Collapsing Glomerulopathy with Donor Apolipoprotein L1 Risk Variants in Kidney Allografts from Black DonorsIbrahim Batal, Alexei V Mikhailov, Syed A Husain, et al.
Clinical Transplantation|April 28, 2025
Rethinking the Diagnosis and Management of Antibody-Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group RecommendationsRuth Sapir-Pichhadze, Medhat Askar, Matthew Cooper, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to TreatmentCarmen Lefaucheur, Denis Viglietti, Luis G Hidalgo, et al.
Pageof 12